Thursday, August 2, 2012

HIV and Hepatitis C

Vincent Lo Re of the University of Pennsylvania. 
Image ©Liz Highleyman /
Researchers in the US compared rates of liver disease and liver-related death between co-infected and hepatitis C-monoinfected people.
Importantly, the co-infected participants were on HIV treatment, which has previously been shown to slow the progression of liver disease.
Co-infected people were at approximately twice the risk of developing decompensated liver disease and 69% more likely to progress to liver cancer.
An undetectable HIV viral load reduced the risk of liver disease, but even with HIV suppression outcomes were still poorer in co-infected people compared to those who only had hepatitis C.

No comments: